New heart stent study aims to improve artery treatment
NCT ID NCT05981911
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study compares a new type of heart stent (XIENCE Skypoint) with other drug-coated stents in 2000 people with coronary artery disease. The goal is to see which stent is more effective and safer in real-world use. Participants will be followed for at least one year to track outcomes like death, heart attack, or the need for another procedure.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CORONARY ARTERY DISEASE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Asan Medical Hospital
RECRUITINGSeoul, South Korea
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Software-Guided heart procedures: a new standard for coronary care?
- Heart patients may stay active longer with coach calls and group support
- Sitting less could be a lifeline for frail hearts – a new trial tests a simple program
- Can balloon timing make or break heart artery success?
- Can we predict which heart aneurysms will grow?
- Can a higher dose of adenosine sharpen heart scans?